Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.01 – $5.00
1% from low
Exchange
OTC Link
CS
Borrow rate
8.49%
Hard to borrow
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.3M | $28.3K | $143.3K | $0 | $0 | $0 | $0 | $0 |
| Cost of revenue | $512.4K | $9.7K | $35.7K | $11.3K | $536 | $10.5K | $8.9K | $5.6K |
| Gross profit | $771.8K | $18.6K | $107.7K | −$11.3K | −$536 | −$10.5K | −$8.9K | −$5.6K |
| Gross margin | 60.1% | 65.7% | 75.1% | — | — | — | — | — |
| R&D | $0 | $0 | $0 | $27.5K | $734.0K | $657.7K | $798.2K | $773.3K |
| Operating income | −$2.4M | −$1.0M | −$518.0K | −$916.4K | −$2.0M | −$2.1M | −$2.5M | −$2.5M |
| EBITDA | −$2.8M | −$1.7M | $73.8K | −$905.1K | −$2.5M | −$2.1M | −$2.4M | −$2.5M |
| Net income | −$4.3M | −$2.6M | −$3.1M | −$1.6M | −$3.4M | −$3.7M | −$4.1M | −$3.3M |
| Net margin | -331.0% | -9243.2% | -2183.8% | — | — | — | — | — |
| EPS (diluted) | -13.54 | -6.04 | -5.78 | -0.22 | -0.09 | -3.97 | -3.77 | -2.51 |
Annual figures · source: Financial Modeling Prep
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $7M | $-300.00 | $-300.00–$-300.00 | 1 |
| 2027 | $15M | $60.00 | $60.00–$60.00 | 1 |
| 2028 | $26M | $540.00 | $540.00–$540.00 | 1 |
| 2029 | $26M | $-2.40 | $-2.40–$-2.40 | 1 |
Forward consensus · source: Financial Modeling Prep
SIGYN THERAPEUTICS INC
No one on the platform currently holds SIGY.
No tracked institution reports a position in SIGY as of their last filing.
| Execution date | Ratio |
|---|---|
| 2024-01-31 | 1-for-40reverse |
| 2004-10-19 | 3-for-1 |
No one on the platform has traded SIGY yet.
| $2565 |
| — |
| IRMEIR-Med Inc. | $0.01 | +0.00% | $540673 | — |
| LMLLFPharmadrug Inc. | $0.01 | +7.50% | $651569 | — |
Source: Financial Modeling Prep · peers by sector/industry
Click to see transaction details on SEC.gov. Form 4s cover trades by officers, directors, and 10%+ owners, due within 2 business days of the trade.
$OGEN crushing $SIGY dilution and near certain failure of the nasal scam in the phase II clinical trials to look forward to here.
View on StockTwits ↗$OGEN Scam and fraud company with continual and ongoing pivots to decreasingly credible lead products. It looks like $SIGY is the new garbage bag pivot that will lead to inevitable dilution and issues with listing compliance.
View on StockTwits ↗@darkreef333 yeah such great news that everyone is dumping 😂😂 $SIGY
View on StockTwits ↗$OGEN 3 trading days since the “news” and $OGEN IS DOWN 21%, and $SIGY is down around 30%. Glad people aren’t falling for their bs scamming anymore
View on StockTwits ↗@darkreef333 why $SIGY? Is there potential here?
View on StockTwits ↗$SIGY $HIMS These two stocks are my biggest holdings
View on StockTwits ↗$SIGY .10 and just starting. $100K market cap. This could def see $1
View on StockTwits ↗https://nfne.ws/271325 $SIGY #ldmicro #Publishing #OTC #OTCMarkets #OTCStocks #Investing
View on StockTwits ↗$SIGY Best kept secret on Wall Street likely to explode in value soon. Very few shares of buying will spike price over $10.
View on StockTwits ↗https://nfne.ws/270888 $SIGY #ldmicro #Publishing #OTC #OTCMarkets #OTCStocks #Investing
View on StockTwits ↗$SIGY Brilliant piece that captures SIGY's situation perfectly. So if you want to update your understanding of SIGY or get to know SIGY better, this is essential reading. https://beyondspx.com/quote/SIGY/analysis/sigyn-therapeutics-addressing-global-health-crises-with-novel-blood-purification-sigy
View on StockTwits ↗$SIGY Sigyn vs. Statins: Better and Faster Sigyn Therapy™ dramatically outperforms statins: - Works in a single session versus weeks or months for statins. - Lowers both LDL-C and Lp(a), unlike statins. - Reduces inflammation and immediate MACE risk. - Safe and effective for statin-intolerant patients. $PFE $BMY $DVA
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.